Skip to contentL
Lifecore Biomedical, Inc.
L
LFCRLifecore Biomedical, Inc. Q1 2015 · 10-Q
Revenue$133.61M$133.61M+22.0% vs Q1 2014 Net Income$2.35M$2.35M−50.5% vs Q1 2014 EPS Diluted$0.09$0.09−50.0% vs Q1 2014 Gross Profit$14,188,000+13.2% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lifecore Biomedical, Inc. · CIK 1005286 · Engraved from SEC EDGAR
Operating Cash Flow$3,943,000−13.1% Free Cash Flowderived-$155,000N/M Margins · derivedGross margin10.6%−0.8 pt vs Q1 2014
Operating margin2.6%+0.8 pt vs Q1 2014
Net margin1.8%−2.6 pt vs Q1 2014
ended Aug 31, 2014 · filed Oct 8, 2014 · 38 d after period end